文献速递艾滋病与性传播感染医院感染防控

法国全国HIV队列实现90-90-90第二、三目标后原发与新近HIV感染显著下降

Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.
PubMed 文献 · Clin Infect Dis · 2020-01-01

第二、三目标分别于2014年和2013年达成,2013年起原发HIV感染下降35.1%、新近HIV感染下降25.4%,诊断至启动cART中位延迟由9.07个月降至0.77个月。

要点

  • 法国2013–2014年达成90-90-90第二、三目标。
  • 2013年起原发HIV感染下降35.1%,新近感染下降25.4%。
  • 诊断至cART启动中位延迟由2007年9.07个月降至2017年0.77个月。

核心结论

  • 法国实现90-90-90第二、三目标并早期启动cART,伴随2013–2017年间原发和新近HIV感染约减少三分之一。

研究设计与样本

  • 采用单断点线性分段回归分析识别趋势变化。

主要发现

  • 研究期间2027例(10.0%)为原发HIV感染,7314例(36.1%)为新近HIV感染。
  • 第二、三目标分别于2014年和2013年达成。
  • 诊断至cART启动中位延迟从2007年9.07个月(IQR 1.39–33.47)降至2017年0.77个月(IQR 0.37–1.60)。
  • 2013年起原发HIV感染下降35.1%,新近HIV感染下降25.4%。
  • 原发HIV感染断点为2012.6(95%CI 2010.8–2014.4),新近HIV感染断点为2013.1(95%CI 2011.3–2014.8)。

关键数值与推荐

  • 新近HIV感染定义为诊断时CD4细胞计数≥500/mm³。
  • 第二目标为90%已诊断者持续接受cART,第三目标为其中90%病毒学控制。

临床怎么用

  • 提示实现治疗覆盖与病毒学控制目标并早期启动cART,可能有助于降低HIV新发感染。
  • 临床应尽早启动cART以缩短诊断至治疗延迟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of CD4 cell count. METHODS: To assess the impact of achieving the second and third Joint United Nations Programme on HIV/AIDS 90-90-90 targets (ie, 90% of diagnosed people on sustained cART, and, of those, 90% virologically controlled) on human immunodeficiency virus (HIV) incidence, we conducted a longitudinal study to describe the epidemiology of primary HIV infection (PHI) and/or recent HIV infection (patients with CD4 cell count ≥500/mm3 at HIV diagnosis; (PRHI) between 2007 and 2017 in a large French multicenter cohort. To identify changes in trends in PHI and PRHI, we used single breakpoint linear segmented regression analysis. RESULTS: During the study period, 61 822 patients were followed in the Dat'AIDS cohort; 2027 (10.0%) had PHI and 7314 (36.1%) had PRHI. The second and third targets were reached in 2014 and 2013, respectively. The median delay between HIV diagnosis and cART initiation decreased from 9.07 (interquartile range [IQR], 1.39-33.47) months in 2007 to 0.77 (IQR, 0.37-1.60) months in 2017. A decrease in PHI (-35.1%) and PRHI (-25.4%) was observed starting in 2013. The breakpoints for PHI and PRHI were 2012.6 (95% confidence interval [CI], 2010.8-2014.4) and 2013.1 (95% CI, 2011.3-2014.8), respectively. CONCLUSIONS: Our findings show that the achievements of 2 public health targets in France and the early initiation of cART were accompanied by a reduction of about one-third in PHI and PRHI between 2013 and 2017. CLINICAL TRIALS REGISTRATION: NCT02898987.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Le Guillou A, Pugliese P, Raffi F, et al. Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort. Clin Infect Dis. 2020. PMID: 31612225. doi:10.1093/cid/ciz800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。